Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.

Samsky, Marc D; Hellkamp, Anne; Hiatt, William R; Fowkes, F Gerry R; Baumgartner, Iris; Berger, Jeffrey S; Katona, Brian G; Mahaffey, Kenneth W; Norgren, Lars; Blomster, Juuso I; Rockhold, Frank W; DeVore, Adam D; Patel, Manesh R; Jones, W Schuyler

Samsky, Marc D; Hellkamp, Anne; Hiatt, William R; Fowkes, F Gerry R; Baumgartner, Iris; Berger, Jeffrey S; Katona, Brian G; Mahaffey, Kenneth W; Norgren, Lars; Blomster, Juuso I; Rockhold, Frank W; DeVore, Adam D; Patel, Manesh R; Jones, W Schuyler.

Afiliação

Samsky MD; Duke Heart Center Duke University Medical CenterDuke Clinical Research InstituteDuke University School of Medicine Durham NC.
Hellkamp A; Duke Heart Center Duke University Medical CenterDuke Clinical Research InstituteDuke University School of Medicine Durham NC.
Hiatt WR; University of Colorado School of Medicine and CPC Clinical Research Aurora CO.
Fowkes FGR; Usher Institute of Population Health Sciences and Informatics University of Edinburgh United Kingdom.
Baumgartner I; Swiss Cardiovascular Centre, Inselspital Bern University HospitalUniversity of Bern Switzerland.
Berger JS; Departments of Medicine and Surgery New York University School of Medicine New York NY.
Katona BG; AstraZeneca Gaithersburg Gaithersburg MD.
Mahaffey KW; Stanford Center for Clinical Research Stanford University School of Medicine Stanford CA.
Norgren L; Faculty of Medicine and Health Örebro University Örebro Sweden.
Blomster JI; Heart Centre Turku University Hospital Turku Finland.
Rockhold FW; Duke Heart Center Duke University Medical CenterDuke Clinical Research InstituteDuke University School of Medicine Durham NC.
DeVore AD; Duke Heart Center Duke University Medical CenterDuke Clinical Research InstituteDuke University School of Medicine Durham NC.
Patel MR; Duke Heart Center Duke University Medical CenterDuke Clinical Research InstituteDuke University School of Medicine Durham NC.
Jones WS; Duke Heart Center Duke University Medical CenterDuke Clinical Research InstituteDuke University School of Medicine Durham NC.

J Am Heart Assoc ; 10(12): e018684, 2021 06 15.

Article em En | MEDLINE | ID: mdl-34056910

Assuntos

Clopidogrel/uso terapêutico; Insuficiência Cardíaca/complicações; Doença Arterial Periférica/tratamento farmacológico; Inibidores da Agregação Plaquetária/uso terapêutico; Antagonistas do Receptor Purinérgico P2Y/uso terapêutico; Ticagrelor/uso terapêutico; Fatores Etários; Idoso; Clopidogrel/efeitos adversos; Comorbidade; Feminino; Insuficiência Cardíaca/diagnóstico; Insuficiência Cardíaca/mortalidade; Hospitalização; Humanos; Masculino; Pessoa de Meia-Idade; Doença Arterial Periférica/complicações; Doença Arterial Periférica/diagnóstico; Doença Arterial Periférica/mortalidade; Inibidores da Agregação Plaquetária/efeitos adversos; Antagonistas do Receptor Purinérgico P2Y/efeitos adversos; Ensaios Clínicos Controlados Aleatórios como Assunto; Medição de Risco; Fatores de Risco; Ticagrelor/efeitos adversos; Fatores de Tempo; Resultado do Tratamento

Palavras-chave

heart failure; outcomes; peripheral artery disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Doença Arterial Periférica / Antagonistas do Receptor Purinérgico P2Y / Clopidogrel / Ticagrelor / Insuficiência Cardíaca Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google